Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4604 Germline predisposition to neuroendocrine tumours of the pancreas (pNEN) based on mutations in DNA repair genes – BRCA1, BRCA2, PALB2, CHEK2, MLH1, MSH2, MSH6, PMS2, EPCAM, APC, MUTYH, STK11

Introduction: Neuroendocrine tumours of the pancreas (pNEN) rank as the second most common epithelial neoplasms after pancreatic adenocarcinoma, with increasing prevalence and a mortality rate of 60%. Identifying germline mutations in DNA repair genes such as CHEK2, BRCA1/2, and MUTYH within pNEN cases may pave the way for personalised diagnostics and therapies.

Conference:

Presenting Author:

Authors: Jurecka Lubieniecka B, Ros-Mazurczyuk M, Oczko-Wojciechowska M, Cortez A, Handkiewicz-Junak D,

Keywords: pNEN, DNA repair genes,

#3109 Trends of incidence and prognosis of thymic neuroendocrine neoplasms - A survival analysis on 320 patients

Introduction: Thymic NENs (TNENs) accounting for only 0.4% of NENs and 3.5 - 4.3% of anterior mediastinal tumors and are more aggressive than their pulmonary and abdominal counterparts. There is no ENETS guidelines for TNENs currently. Previous studies focused on treatment and outcomes were unsatisfactory.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Liu M, Hu P, Bai J, Zhu G, Tian Y,

Keywords: thymic neuroendocrine neoplasm, incidence, histology, staging system, overall survival,

#1519 Gastric Type I Neuroendocrine Tumors Endoscopic Treatment Options

Introduction: From 1998 till 2014 in our institution we have identified 72 patients with type I gastric neuroendocrine tumors (NET), 42 of them, without regional or distant metastases, undergone different types of endoscopic treatment.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Sokolov V, Pirogov S, Karpova E, Pavlov P, Sokolov D,

Keywords: gastric, NET, endoscopic, EMR, ESD, APC,

#1205 Temozolomid-Based Therapy in GEP-and Bronchopulmonary NEN from a Multicentric Study from Germany

Introduction: Chemotherapy (CTx) with temozolomid as mono (TEM) or combination therapy with capcitabine (TEM/CAP) is a new cytotoxic regimen with good efficiency in pancreatic and bronchopulmonary NET-G1/G2 and NEC-G3.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Maasberg S, Bacher M, Rinke A, Lahner H, Unger N,

Keywords: temozolomide, capecitabine,

#763 Endoscopic Therapy with Argon Plasma Coagulation for Multiple Type 1 Gastric Carcinoid Tumors

Introduction: Data regarding Type I gastric carcinoids and their evolution in prospective series are scarce, thus treatment and follow-up are not codified.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Castano R

Authors: Castano R, Vargas C, Pérez J, Muñoz M, Dueñas J,

Keywords: gastric type I neuroendocrine tumors, endoscopy, Argon plasma coagulation,